ExploreWatchlistsPricing
  1. US-listed companies
  2. Cyclo Therapeutics, Inc.
  3. Financials
  4. Free cash flow

Cyclo Therapeutics, Inc. (CYTH)

Market cap
$20.73M
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 2023-16+6.99%
Dec 31, 2022-15+0.68%
Dec 31, 2021-15+74.88%
Dec 31, 2020-9+30.38%
Dec 31, 2019-7+106.52%
Dec 31, 2018-3+3.98%
Dec 31, 2017-3+3.68%
Dec 31, 2016-3+22.90%
Dec 31, 2015-2+199.20%
Dec 31, 2014-1-301.45%
Dec 31, 20130+77.87%
Dec 31, 20120-161.05%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat